The Research Progress of Herceptin in Treatment of HER-2 Overexpressing Breast Cancer / 昆明医科大学学报
Journal of Kunming Medical University
; (12): 145-148, 2013.
Article
em Zh
| WPRIM
| ID: wpr-440901
Biblioteca responsável:
WPRO
ABSTRACT
Oncogene activation and inactivation of tumor suppressor genes is an important molecular mechanism of tumor formation. HER-2 oncogene is associated with breast cancer invasion and metastasis and prognosis, HER-2 overexpressing breast cancer progresses rapidly and has poor prognosis. In recent years, the emergence of targeted therapeutic monoclonal antibody drug Herceptin which built its structure for the HER-2 has significantly inproved HER-2-positive advanced breast cancer.
Texto completo:
1
Índice:
WPRIM
Idioma:
Zh
Revista:
Journal of Kunming Medical University
Ano de publicação:
2013
Tipo de documento:
Article